Resources

This application note highlights new comparative data on T cell dynamics in HypoSkin^® and InflammaSkin^®, generated using flow cytometric analysis.

ProtocolNativeSkin® Approved Protocols Please fill in the form below to access the protocols. Need more info? Please contact us! Contact us

Research HighlightExplore our latest publication in Allergy: the story behind the idea and key findings.The landscape of vaccine research is undergoing an important transformation, thanks to the breakthroughs in mRNA vaccine technology. This innovation has catalyzed the development of vaccines that are not only highly effective but also rapidly deployable at a large scale. With the increasing number of researchRead more

In this white paper, discover new validation data demonstrating the stability, injectability and immunocompetency of our HypoSkin^® model.

Mast CellsSingle-cell profiling of biostabilized natural human skin identifies mast cells as an important target of injected mRNA-1273 COVID-19 vaccine. Research by M. Scholaert1,2, M. Peries2, E. Braun2, J. Martin1, N. Serhan1, A. Loste1, A. Bruner1, L. Basso1, E. Merle2, A. Trevisiol2, E. Pagès2 and N. Gaudenzio1,2 1Toulouse Insitute for Infectious and Inflammatory Diseases (Infinity), 2Genoskin The field of vaccinationRead more

Skin MicrobiomeA fully functional ex vivo human skin model to study human skin microbiome Research by B. Coupe1, M. Pastore2, E. Pagès2, E. Braun2, A. Broha1, P. Descargues2 1Vaiomer, 2Genoskin The human skin is colonized by a diverse population of microorganisms. The symbiotic host-microorganism relationship can be affected by numerous endogenous and exogenous factors. This can result in skin disordersRead more